Evidence map›Paper›PMID 25252176›Full record

ArticleJournal of molecular and cellular cardiology2014

Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Hussam E Salhi, Shane D Walton, Nathan C Hassel, Elizabeth A Brundage, Pieter P de Tombe, Paul M L Janssen, Jonathan P Davis, Brandon J Biesiadecki

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Molecular regulation of stretch activation.American journal of physiology. Cell physiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. NHJournal of cellular signaling · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hussam E SalhiThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Shane D WaltonThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Nathan C HasselThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Elizabeth A BrundageThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Pieter P de TombeThe Department of Cell and Molecular Physiology, Health Sciences Division, Loyola University Chicago, Maywood, IL 60153, USA.
Paul M L JanssenThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Jonathan P DavisThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Brandon J BiesiadeckiThe Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA; The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA. Electronic address: biesiadecki.1@osu.edu.
The Ohio State University · USLung Institute · USLoyola University Chicago · US

Funding

Sarcomeric Modifications and Progressive Cardiac MaladaptationP01HL062426 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN · 2000 to 2020
$42.4M
Frequency-dependent modulation of cardiac myofilament function in health/diseaseR01HL113084 · NHLBI · OHIO STATE UNIVERSITY · PI JANSSEN, PAULUS ML · 2012 to 2023
$4.6M
Integrated Crosstalk of Thin Filament Post-translational ModificationsR01HL114940 · NHLBI · OHIO STATE UNIVERSITY · PI BIESIADECKI, BRANDON J · 2013 to 2021
$3.6M
Frank-Starling's Law of the Heart: Cellular MechanismsR01HL075494 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DE TOMBE, PIETER P. · 2005 to 2012
$3.0M
Role of Cardiac Troponin in Health and DiseaseR01HL091986 · NHLBI · OHIO STATE UNIVERSITY · PI DAVIS, JONATHAN PAUL · 2010 to 2014
$1.9M
Role of Cardiac Troponin in Health and DiseaseR56HL091986 · NHLBI · OHIO STATE UNIVERSITY · PI DAVIS, JONATHAN PAUL · 2015 to 2015
$379k
NHLBI NIH HHS HL091986NHLBI NIH HHS HL113084NHLBI NIH HHS HL114940NHLBI NIH HHS HL62426NHLBI NIH HHS HL75494NHLBI NIH HHS P01 HL062426NHLBI NIH HHS R01 HL075494NHLBI NIH HHS R01 HL091986NHLBI NIH HHS R01 HL113084NHLBI NIH HHS R01 HL114940NHLBI NIH HHS R56 HL091986
6 · The paper itself

Abstract

Troponin I (TnI), the inhibitory subunit of the troponin complex, can be phosphorylated as a key regulatory mechanism to alter the calcium regulation of contraction. Recent work has identified phosphorylation of TnI Tyr-26 in the human heart with unknown functional effects. We hypothesized that TnI Tyr-26N-terminal phosphorylation decreases calcium sensitivity of the thin filament, similar to the desensitizing effects of TnI Ser-23/24 phosphorylation. Our results demonstrate that Tyr-26 phosphorylation and pseudo-phosphorylation decrease calcium binding to troponin C (TnC) on the thin filament and calcium sensitivity of force development to a similar magnitude as TnI Ser-23/24 pseudo-phosphorylation. To investigate the effects of TnI Tyr-26 phosphorylation on myofilament deactivation, we measured the rate of calcium dissociation from TnC. Results demonstrate that filaments containing Tyr-26 pseudo-phosphorylated TnI accelerate the rate of calcium dissociation from TnC similar to that of TnI Ser-23/24. Finally, to assess functional integration of TnI Tyr-26 with Ser-23/24 phosphorylation, we generated recombinant TnI phospho-mimetic substitutions at all three residues. Our biochemical analyses demonstrated no additive effect on calcium sensitivity or calcium-sensitive force development imposed by Tyr-26 and Ser-23/24 phosphorylation integration. However, integration of Tyr-26 phosphorylation with pseudo-phosphorylated Ser-23/24 further accelerated thin filament deactivation. Our findings suggest that TnI Tyr-26 phosphorylation functions similarly to Ser-23/24N-terminal phosphorylation to decrease myofilament calcium sensitivity and accelerate myofilament relaxation. Furthermore, Tyr-26 phosphorylation can buffer the desensitization of Ser-23/24 phosphorylation while further accelerating thin filament deactivation. Therefore, the functional integration of TnI phosphorylation may be a common mechanism to modulate Ser-23/24 phosphorylation function.

Indexed as

Protein Processing, Post-TranslationalAnimalsCalciumCalcium SignalingHeart Conduction SystemHumansMyocardial ContractionMyofibrilsPhosphorylationRatsTroponin ITyrosineCalciumTroponin ITyrosineCalcium sensitivityCardiac troponin IThin filament deactivationTyrosine phosphorylation

Identifiers

PMID25252176
PMCPMC4250312
OpenAlexW2095132421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.